Form 4: Annexon Director Boosts Stake with Stock Purchase

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at an average price of $3.17 per share.

Summary

• William H. Carson, a Director of Annexon, Inc. (ANNX), acquired 4,115 shares of the company's common stock.
• The transaction occurred on October 30, 2025, at a weighted average purchase price of $3.17 per share.
• The shares were purchased through multiple trades at prices ranging from $3.15 to $3.20, inclusive.
• This acquisition was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Carson on March 17, 2025.
• Following this transaction, Mr. Carson beneficially owns 46,175 shares of Annexon, Inc. common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director is generally viewed as a positive signal, indicating management's belief in the company's value and future prospects. The transaction being part of a 10b5-1 plan adds a layer of pre-planned confidence.

Positives

• A director's purchase of company stock signals confidence in the company's future prospects and current valuation.
• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned investment rather than a reactive one.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's operations or financial performance.

Management Comments

• Director William H. Carson's purchase of additional shares signals confidence in Annexon, Inc.'s current valuation and future outlook.

Industry Context

Insider purchases, particularly by directors, are often interpreted by the market as a signal of confidence in the company's future prospects, potentially indicating that the director believes the stock is undervalued. This can be a positive indicator for investors in the biotechnology sector, where company-specific developments often drive stock performance.

Comparison to Industry Standards

• Not applicable as this filing reports an individual insider transaction, not company performance metrics or project results.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's confidence, potentially influencing investor sentiment and demand for the stock.

Key Dates

Recommendation

The purchase of company stock by a director, especially under a pre-arranged 10b5-1 plan, typically signals strong insider confidence in the company's future performance and valuation. This action suggests that a key insider believes the stock is a good investment at current prices, which can be a compelling reason for other investors to consider a 'buy' position, assuming it aligns with their overall investment strategy and risk tolerance.

Keywords

Annexon, ANNX, Form 4, Insider Trading, Director Purchase, Stock Acquisition, 10b5-1 Plan, Biotechnology